Unspecified Adult Solid Tumor, Protocol Specific

6

Review clinical trials related to Unspecified Adult Solid Tumor, Protocol Specific. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Registry of Older Patients With Cancer

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.

Participants needed: 3,000
Trial details
Age: 65+Biological sex: AllType: ObservationalSponsor: UNC Lineberger Comprehensive Cancer CenterUpdated: Jun 29, 2026Locations: 7
Eligibility criteria

Patients must have an appointment at the North Carolina Cancer Hospital and agre... [+2]

Status: Recruiting

Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

RATIONALE: Collecting and storing samples of tissue or blood from patients with cancer for study in the laboratory may help the study of cancer in the future PURPOSE: This research study is collecting and storing blood and tissue samples from patients with suspected solid tumors.

Participants needed: 20,000
Trial details
Age: 18-120Biological sex: AllType: ObservationalSponsor: Wake Forest University Health SciencesUpdated: Mar 19, 2026Locations: 1Duration: 1 Day
Eligibility criteria

Signed protocol specific informed consent prior to registration/randomization. [+1]

Status: Recruiting

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

This research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer). Genomic profiling studies the deoxyribonucleic acid (DNA) of a tumor to detect genetic changes or abnormalities. This information can then be used to recommend treatments that may be more likely to result in a beneficial response. It is not yet known whether genomic profiling will detect abnormalities that can be used to make treatment recommendations and whether treatment based on genomic profiling is more effective than standard treatment.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Stanford UniversityUpdated: Dec 24, 2025Locations: 1
Eligibility criteria

Understand and provide written informed consent and Health Insurance Portability... [+6]

Have lesions that are not accessible to biopsy or not planned for biopsy as part... [+5]

Status: Recruiting

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in patients with HRD/FAD solid tumours or tumor types with high incidence of HRD/FAD in monotherapy or in combination with carboplatin or patients with solid tumour and oligoprogressive disease receiving immune checkpoint inhibitors (ICI): a phase I-IIa clinical trial

Participants needed: 126
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Maastricht University Medical CenterUpdated: Oct 7, 2025Locations: 5
Eligibility criteria

Male or female, aged 18 years or more at the time of signing the informed consen... [+14]

Prior radiotherapy to more than 25% of bone marrow [+30]

Status: Recruiting

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This phase I trial is studying FLT PET imaging in patients with cancer.

Trial details
Age: 18-120Biological sex: AllType: InterventionalSponsor: Barbara Ann Karmanos Cancer InstituteUpdated: Jul 8, 2025Locations: 1
Eligibility criteria

Histologically confirmed solid tumor or hematologic malignancy [+7]

Status: Recruiting

Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting tissue samples from patients with cancer undergoing radiation therapy. Healthy participants will also be allowed on the trial so their samples can be used in comparison to patients with malignancy

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Texas Southwestern Medical CenterUpdated: May 14, 2025Locations: 1
Eligibility criteria

Pathologically-proven diagnosis of malignancy [+10]